125 related articles for article (PubMed ID: 1906098)
1. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.
Walter EB; Drucker RP; McKinney RE; Wilfert CM
J Pediatr; 1991 Jul; 119(1 Pt 1):152-5. PubMed ID: 1906098
[No Abstract] [Full Text] [Related]
2. Analysis of myopathy in a placebo-controlled zidovudine trial.
Simpson DM; Slasor P; Dafni U; Berger J; Fischl MA; Hall C
Muscle Nerve; 1997 Mar; 20(3):382-5. PubMed ID: 9052824
[No Abstract] [Full Text] [Related]
3. [Myopathy and zidovudine].
Mateo O; Gato A; Ballesteros P; Benito L; Pontes MJ; Esquinas G
Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):474-6. PubMed ID: 1489776
[TBL] [Abstract][Full Text] [Related]
4. Myopathy associated with human immunodeficiency virus (HIV) but not with zidovudine.
Simpson DM
Ann Intern Med; 1988 Nov; 109(10):842. PubMed ID: 3190033
[No Abstract] [Full Text] [Related]
5. Exacerbation of HIV-associated myopathy by zidovudine.
Berger JR; Shebert R; Gregorios JB
AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
[No Abstract] [Full Text] [Related]
6. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
Peters BS; Winer J; Landon DN; Stotter A; Pinching AJ
Q J Med; 1993 Jan; 86(1):5-15. PubMed ID: 8438050
[TBL] [Abstract][Full Text] [Related]
9. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.
Manji H; Harrison MJ; Round JM; Jones DA; Connolly S; Fowler CJ; Williams I; Weller IV
J Neurol; 1993 Sep; 240(8):479-88. PubMed ID: 8263554
[TBL] [Abstract][Full Text] [Related]
10. Myalgias in human immunodeficiency virus-infected patients.
Buskila D; Langevitz P
Am J Med; 1989 Apr; 86(4):510-1. PubMed ID: 2929650
[No Abstract] [Full Text] [Related]
11. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
Schröder JM; Bertram M; Schnabel R; Pfaff U
Acta Neuropathol; 1992; 85(1):39-47. PubMed ID: 1285495
[TBL] [Abstract][Full Text] [Related]
12. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?
Till M; MacDonell KB
Ann Intern Med; 1990 Oct; 113(7):492-4. PubMed ID: 1975486
[No Abstract] [Full Text] [Related]
13. Skeletal myopathy associated with nucleoside reverse transcriptase inhibitor therapy: potential benefit of coenzyme Q10 therapy.
Rosenfeldt FL; Mijch A; McCrystal G; Sweeney C; Pepe S; Nicholls M; Dennett X
Int J STD AIDS; 2005 Dec; 16(12):827-9. PubMed ID: 16336769
[TBL] [Abstract][Full Text] [Related]
14. Necrotising myopathy and zidovudine.
Lancet; 1988 May; 1(8593):1050-1. PubMed ID: 2896888
[No Abstract] [Full Text] [Related]
15. Zidovudine experience at the Hospitals for Sick Children, Great Ormond Street, London.
Ball LM
J Infect; 1989 Jan; 18 Suppl 1():83. PubMed ID: 2915142
[No Abstract] [Full Text] [Related]
16. Criteria for use of zidovudine in adult and pediatric inpatients and outpatients.
Goodwin SD; Shipp KW
Clin Pharm; 1992 Jan; 11(1):63-8. PubMed ID: 1730181
[No Abstract] [Full Text] [Related]
17. Mitochondrial myopathy caused by long-term zidovudine therapy.
Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
[TBL] [Abstract][Full Text] [Related]
18. [Muscular involvement in human immunodeficiency virus infection].
Laraki R; Lebas J; Baudrimont M; Cabane J; Giral P; Wattiaux MJ; Picard O; Imbert JC
Ann Med Interne (Paris); 1990; 141(2):187-92. PubMed ID: 2191617
[No Abstract] [Full Text] [Related]
19. [Long-term success with zidovudine in HIV infection].
Leber Magen Darm; 1989 May; 19(3):158. PubMed ID: 2500573
[No Abstract] [Full Text] [Related]
20. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
McKinney RE; Pizzo PA; Scott GB; Parks WP; Maha MA; Lehrman SN; Riggs M; Eddy J; Lane BA; Eppes SC
J Pediatr; 1990 Apr; 116(4):640-7. PubMed ID: 2181102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
